Current status: Open
Opened on 5 December 2024 and will close for consultation on 19 January 2025.
Health Canada’s Pest Management Regulatory Agency (PMRA), under the authority of the Pest Control Products Act, is proposing registration for the sale and use of Beauveria bassiana strain ANT-03 and BioTitan WP, containing the active ingredient Beauveria bassiana strain ANT-03, for reduction in numbers of tarnished plant bug on industrial hemp grown outdoors; and for the reduction in numbers of whiteflies, aphids, and thrips on outdoor ornamentals, including transplants.
How to get involved
This consultation is open for comment from 5 December 2024 to 19 January 2025 (45Â calendar days). Open the “Consultation Summary” to access the document.
If you would like to comment, see the Pest Management Regulatory Agency Publications Section page for contact information. Please be sure to include the title of the consultation document on which you are commenting.
Health Canada will consider all comments received up to 45 days from the date of publication of this document (by 19 January 2025) before making a final decision on the proposed registration for Beauveria bassiana strain ANT-03 and BioTitan WP.
Reporting to Canadians
Health Canada will make the results of this consultation available on this website. Once the decision on Beauveria bassiana strain ANT-03 and BioTitan WP is finalized, the PMRA will post a Registration Decision on the Pesticides and Pest Management Reports and Publications portion of Canada.ca.
If you have any questions, contact the Pest Management Information Service.
Interested in our other consultations? Sign up and stay informed about topics that matter to you.